References
- Center for Reproductive Rights. Women of the world: Laws and policies affecting their reproductive lives–East Central Europe. Center for Reproductive Rights, New York 2003
- Herold J, Seither R, Ylli A, et al. Reproductive Health Survey, Albania 2002: Preliminary Report. Centre for Disease Control, Atlanta, GA, USA 2003
- Nuri B. Health Care Systems in Transition: Albania, E Trageakes. European Observatory on Health Care Systems, Copenhagen 2002, 4(6)
- Hausknecht R. Mifepristone and misoprostol for early medical abortion: 18 months experience in the United States. Contraception 2003; 67: 463–465
- World Health Organization Task Force on Post-ovulatory methods of Fertility Regulation. Comparison of two doses of mifepristone in combination with misoprostol for early abortion: A randomised trial. Br J Obstet Gynaecol 2000; 107: 524–530
- Schaff E, Eisinger S, Stadalius L, et al. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion. Contraception 1999; 59: 1–6
- Elul B, Hajri S, Ngoc NN, et al. Can women in less-developed countries use a simplified medical abortion regimen?. Lancet 2001; 357: 1402–1405
- Hagri S, Blum J, Gueddana N, et al. Expanding medical abortion in Tunisia: Women's experience from a multi-site expansion study. Contraception 2004; 70: 486–491
- Blum J, Hajri S, Chelli H, et al. The medical abortion experiences of married and unmarried women in Tunis, Tunisia. Contraception 2004; 69: 63–69
- Akin A, Blum J, Ozalp S, et al. Results and lessons learned from a small medical abortion clinical study in Turkey. Contraception 2004; 70: 401–406
- Winikoff B, Ellertson C, Clark S. Analysis of failure in medical abortion. Contraception 1996; 54: 323–327
- Comendant R. Acceptability and Feasibility of Medical Abortion in Moldova: Preliminary Results. Presentation at meeting Medical Abortion in Ukraine: Promoting Awareness and Enhancing Service Delivery, Kiev, Ukraine, 2 October, 2005